VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,800 | -10.7% | 2,000 | 0.0% | 0.02% | -7.4% |
| Q2 2023 | $60,220 | -6.9% | 2,000 | 0.0% | 0.03% | -10.0% |
| Q1 2023 | $64,680 | +12.9% | 2,000 | 0.0% | 0.03% | +11.1% |
| Q4 2022 | $57,300 | +19.4% | 2,000 | 0.0% | 0.03% | +8.0% |
| Q3 2022 | $48,000 | -12.7% | 2,000 | 0.0% | 0.02% | -3.8% |
| Q2 2022 | $55,000 | -28.6% | 2,000 | 0.0% | 0.03% | -21.2% |
| Q1 2022 | $77,000 | +20.3% | 2,000 | 0.0% | 0.03% | +32.0% |
| Q4 2021 | $64,000 | +8.5% | 2,000 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $59,000 | -13.2% | 2,000 | 0.0% | 0.02% | -10.7% |
| Q2 2021 | $68,000 | +4.6% | 2,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $65,000 | -9.7% | 2,000 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $72,000 | -7.7% | 2,000 | 0.0% | 0.03% | -15.4% |
| Q3 2020 | $78,000 | +6.8% | 2,000 | 0.0% | 0.04% | +2.6% |
| Q2 2020 | $73,000 | +143.3% | 2,000 | +53.8% | 0.04% | +111.1% |
| Q1 2020 | $30,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |